• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

α-突触核蛋白特异性调节性 T 细胞改善小鼠帕金森病进展。

Alpha-Synuclein-Specific Regulatory T Cells Ameliorate Parkinson's Disease Progression in Mice.

机构信息

Department of Science in Korean Medicine, College of Korean Medicine, Graduate School, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea.

Department of Korean Medicine, College of Korean Medicine, Graduate School, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea.

出版信息

Int J Mol Sci. 2023 Oct 16;24(20):15237. doi: 10.3390/ijms242015237.

DOI:10.3390/ijms242015237
PMID:37894917
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10607030/
Abstract

Parkinson's disease (PD) is a long-term neurodegenerative disease characterized by dopaminergic neuronal loss and the aggregation of alpha-synuclein (α-syn) in the brain. Cell therapy using regulatory T cells (Tregs) has therapeutic potential on PD progression in a mouse model; however, several challenges were associated with its applications. Here, we propose a strategy for α-syn specific Treg expansion (α-syn Treg). We presented α-syn to T cells via dendritic cells. This method increased the mobility of Tregs towards the site of abundant α-syn in vitro ( < 0.01; α-syn Tregs versus polyclonal Tregs (poly Tregs)) and in vivo. Consequently, α-syn Tregs showed noteworthy neuroprotective effects against motor function deficits ( < 0.05, < 0.01; α-syn Tregs versus poly Tregs), dopaminergic neuronal loss ( < 0.001; α-syn Tregs versus poly Tregs), and α-syn accumulation ( < 0.05; α-syn Tregs versus poly Tregs) in MPTP-induced PD mice. Furthermore, the adoptive transfer of α-syn Tregs exerted immunosuppressive effects on activated microglia, especially pro-inflammatory microglia, in PD mice. Our findings suggest that α-syn presentation may provide a significant improvement in neuroprotective activities of Tregs and suggest the effective clinical application of Treg therapy in PD.

摘要

帕金森病(PD)是一种长期的神经退行性疾病,其特征是多巴胺能神经元丧失和脑内α-突触核蛋白(α-syn)的聚集。使用调节性 T 细胞(Tregs)的细胞疗法在 PD 小鼠模型中具有治疗进展的潜力;然而,其应用存在一些挑战。在这里,我们提出了一种针对α-syn 的 Treg 特异性扩增(α-syn Treg)策略。我们通过树突状细胞将α-syn 呈递给 T 细胞。这种方法增加了 Tregs 向体外(<0.01;α-syn Tregs 与多克隆 Tregs(多 Tregs))和体内富含α-syn 的部位迁移的能力。因此,α-syn Tregs 对运动功能缺陷(<0.05,<0.01;α-syn Tregs 与多 Tregs)、多巴胺能神经元丧失(<0.001;α-syn Tregs 与多 Tregs)和α-syn 积累(<0.05;α-syn Tregs 与多 Tregs)具有显著的神经保护作用,在 MPTP 诱导的 PD 小鼠中。此外,α-syn Tregs 的过继转移对 PD 小鼠中活化的小胶质细胞(尤其是促炎小胶质细胞)具有免疫抑制作用。我们的研究结果表明,α-syn 的呈递可能显著提高 Treg 的神经保护活性,并提示 Treg 疗法在 PD 中的有效临床应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e0e/10607030/b1249c7a1f8e/ijms-24-15237-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e0e/10607030/5be874685ed6/ijms-24-15237-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e0e/10607030/b81d69958b4e/ijms-24-15237-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e0e/10607030/8824e73a5012/ijms-24-15237-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e0e/10607030/59532978c65c/ijms-24-15237-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e0e/10607030/27d4fc125f61/ijms-24-15237-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e0e/10607030/b1249c7a1f8e/ijms-24-15237-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e0e/10607030/5be874685ed6/ijms-24-15237-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e0e/10607030/b81d69958b4e/ijms-24-15237-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e0e/10607030/8824e73a5012/ijms-24-15237-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e0e/10607030/59532978c65c/ijms-24-15237-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e0e/10607030/27d4fc125f61/ijms-24-15237-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e0e/10607030/b1249c7a1f8e/ijms-24-15237-g006.jpg

相似文献

1
Alpha-Synuclein-Specific Regulatory T Cells Ameliorate Parkinson's Disease Progression in Mice.α-突触核蛋白特异性调节性 T 细胞改善小鼠帕金森病进展。
Int J Mol Sci. 2023 Oct 16;24(20):15237. doi: 10.3390/ijms242015237.
2
α-Synuclein induces Th17 differentiation and impairs the function and stability of Tregs by promoting RORC transcription in Parkinson's disease.α-突触核蛋白通过促进帕金森病中 RORC 转录诱导 Th17 分化,并损害 Treg 的功能和稳定性。
Brain Behav Immun. 2023 Feb;108:32-44. doi: 10.1016/j.bbi.2022.10.023. Epub 2022 Nov 4.
3
Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.抑制JAK/STAT信号通路可预防α-突触核蛋白诱导的神经炎症和多巴胺能神经退行性变。
J Neurosci. 2016 May 4;36(18):5144-59. doi: 10.1523/JNEUROSCI.4658-15.2016.
4
Tolerogenic bone marrow-derived dendritic cells induce neuroprotective regulatory T cells in a model of Parkinson's disease.耐受原骨髓来源的树突状细胞在帕金森病模型中诱导神经保护调节性 T 细胞。
Mol Neurodegener. 2018 May 21;13(1):26. doi: 10.1186/s13024-018-0255-7.
5
Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease.靶向 II 类转录激活因子可减轻帕金森病 α-突触核蛋白模型中的炎症和神经退行性变。
J Neuroinflammation. 2018 Aug 30;15(1):244. doi: 10.1186/s12974-018-1286-2.
6
Cholecystokinin and glucagon-like peptide-1 analogues regulate intestinal tight junction, inflammation, dopaminergic neurons and α-synuclein accumulation in the colon of two Parkinson's disease mouse models.胆囊收缩素和胰高血糖素样肽-1 类似物调节两种帕金森病小鼠模型的肠道紧密连接、炎症、多巴胺能神经元和 α-突触核蛋白的积累。
Eur J Pharmacol. 2022 Jul 5;926:175029. doi: 10.1016/j.ejphar.2022.175029. Epub 2022 May 15.
7
Age-dependent neurodegeneration and neuroinflammation in a genetic A30P/A53T double-mutated α-synuclein mouse model of Parkinson's disease.帕金森病 A30P/A53T 双突变α-突触核蛋白基因敲入小鼠模型中的年龄依赖性神经退行性变和神经炎症。
Neurobiol Dis. 2022 Sep;171:105798. doi: 10.1016/j.nbd.2022.105798. Epub 2022 Jun 21.
8
Combined Active Humoral and Cellular Immunization Approaches for the Treatment of Synucleinopathies.联合主动体液和细胞免疫接种方法治疗突触核蛋白病。
J Neurosci. 2018 Jan 24;38(4):1000-1014. doi: 10.1523/JNEUROSCI.1170-17.2017. Epub 2017 Dec 15.
9
Association Between Decreased Srpk3 Expression and Increased Substantia Nigra Alpha-Synuclein Level in an MPTP-Induced Parkinson's Disease Mouse Model.MPTP诱导的帕金森病小鼠模型中Srpk3表达降低与黑质α-突触核蛋白水平升高之间的关联
Mol Neurobiol. 2023 Feb;60(2):780-788. doi: 10.1007/s12035-022-03104-x. Epub 2022 Nov 12.
10
Cx3cr1-deficiency exacerbates alpha-synuclein-A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease.Cx3cr1 缺陷加剧了 α-突触核蛋白 A53T 诱导的帕金森病小鼠模型中的神经炎症和神经退行性变。
Glia. 2018 Aug;66(8):1752-1762. doi: 10.1002/glia.23338. Epub 2018 Apr 6.

引用本文的文献

1
Immune mechanisms and shared immune targets in neurodegenerative diseases.神经退行性疾病中的免疫机制和共同免疫靶点
Nat Rev Neurol. 2025 Feb;21(2):67-85. doi: 10.1038/s41582-024-01046-7. Epub 2024 Dec 16.
2
Therapeutic Effects of Aβ-Specific Regulatory T Cells in Alzheimer's Disease: A Study in 5xFAD Mice.阿尔茨海默病中 Aβ 特异性调节性 T 细胞的治疗效果:5xFAD 小鼠的研究。
Int J Mol Sci. 2024 Jan 8;25(2):783. doi: 10.3390/ijms25020783.
3
Mitochondrial Dynamics in Neurodegenerative Diseases: Unraveling the Role of Fusion and Fission Processes.

本文引用的文献

1
Corrigendum: Celastrol Downmodulates Alpha-Synuclein-Specific T Cell Responses by Mediating Antigen Trafficking in Dendritic Cells.勘误:雷公藤红素通过介导树突状细胞中的抗原转运来下调α-突触核蛋白特异性T细胞反应。
Front Immunol. 2022 May 20;13:907993. doi: 10.3389/fimmu.2022.907993. eCollection 2022.
2
Toxic Exposure to Endocrine Disruptors Worsens Parkinson's Disease Progression through NRF2/HO-1 Alteration.内分泌干扰物的毒性暴露通过NRF2/HO-1改变加重帕金森病进展。
Biomedicines. 2022 May 5;10(5):1073. doi: 10.3390/biomedicines10051073.
3
T cells, α-synuclein and Parkinson disease.
线粒体动力学在神经退行性疾病中的作用:解析融合和分裂过程
Int J Mol Sci. 2023 Aug 22;24(17):13033. doi: 10.3390/ijms241713033.
T 细胞、α-突触核蛋白与帕金森病。
Handb Clin Neurol. 2022;184:439-455. doi: 10.1016/B978-0-12-819410-2.00023-0.
4
Alpha synuclein, the culprit in Parkinson disease, is required for normal immune function.在帕金森病中起作用的阿尔法突触核蛋白,对于正常的免疫功能也是必需的。
Cell Rep. 2022 Jan 11;38(2):110090. doi: 10.1016/j.celrep.2021.110090.
5
Alpha-Synuclein Induced Immune Cells Activation and Associated Therapy in Parkinson's Disease.α-突触核蛋白诱导的帕金森病免疫细胞激活及相关治疗
Front Aging Neurosci. 2021 Nov 5;13:769506. doi: 10.3389/fnagi.2021.769506. eCollection 2021.
6
Antigen-Specific Regulatory T Cell Therapy in Autoimmune Diseases and Transplantation.抗原特异性调节性 T 细胞治疗自身免疫性疾病和移植。
Front Immunol. 2021 May 14;12:661875. doi: 10.3389/fimmu.2021.661875. eCollection 2021.
7
CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson's disease.CD4 T 细胞在帕金森病小鼠模型中介导脑部炎症和神经退行性变。
Brain. 2021 Aug 17;144(7):2047-2059. doi: 10.1093/brain/awab103.
8
Regulatory T cell therapy: Current and future design perspectives.调节性 T 细胞治疗:当前和未来的设计视角。
Cell Immunol. 2020 Oct;356:104193. doi: 10.1016/j.cellimm.2020.104193. Epub 2020 Aug 12.
9
Bee Venom Phospholipase A2 Induces Regulatory T Cell Populations by Suppressing Apoptotic Signaling Pathway.蜂毒磷脂酶 A2 通过抑制凋亡信号通路诱导调节性 T 细胞群体。
Toxins (Basel). 2020 Mar 22;12(3):198. doi: 10.3390/toxins12030198.
10
2-Pentadecyl-2-Oxazoline Reduces Neuroinflammatory Environment in the MPTP Model of Parkinson Disease.2-十五烷基-2-恶唑啉可减少 MPTP 帕金森病模型中的神经炎症环境。
Mol Neurobiol. 2018 Dec;55(12):9251-9266. doi: 10.1007/s12035-018-1064-2. Epub 2018 Apr 14.